GridAI Technologies Corp. Common Stock (GRDX) Stock Price

GRDXStock
$4.22−13.70%52W
Market Cap$30.09M
P/E—
PEG Ratio—
Div yield—
Beta1.71

GRDX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)94.95%
Price vs S&P 500 (4W)25.44%
VGM Score58.57

GRDX Analyst Recommendations

Dec 2024
Jan 2025
Feb 2025
Mar 2025
4.00
2.17
2.17
2.17

Industry Peers — Electric & Gas Services(30)

SymbolValue ScoreGrowth ScoreMomentum ScoreIndicated Dividend Yield (Annual)P/E Ratio (Annual)Payout Ratio (TTM)Total Debt / Equity (Quarterly)Price
GRDXGridAI Technologies Corp. Common Stock
——C———0.1x$4.22
DUKDuke Energy CorporationCCB4.5%19.1x64.5%1.7x$121.47
XELXcel Energy, Inc.CDC2.9%22.7x61.1%1.7x$76.31
EXCExelon CorporationBDC3.7%16.2x60.0%1.8x$43.50
EDConsolidated Edison, Inc.CCB3.6%20.5x54.8%1.1x$112.26
PCGPG&E CorporationBCD1.1%10.7x13.5%1.9x$13.09
PEGPublic Service Enterprise Group IncorporatedCDD3.5%16.9x64.5%1.4x$71.49
WECWEC Energy Group, Inc.CDC3.3%22.3x70.9%1.6x$108.71
AEEAmeren CorporationCCB3.3%20.2x51.1%1.6x$106.08
CMSCMS Energy CorporationCDC3.4%20.1x67.3%2.0x$68.70
NINiSource Inc.CCC3.8%22.0x61.8%1.8x$42.68

About GridAI Technologies Corp. Common Stock

GridAI Technologies Corp is a late-stage biopharmaceutical company developing non-systemic therapies for gastrointestinal diseases. Key programs include latiglutenase for celiac disease (Phase 3-ready), capeserod for gastroparesis, and adrulipase for pancreatic insufficiency. The company focuses on addressing unmet medical needs in GI health.